News
Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective - and more by some measures - than the original shot, the company said.
But in 2024, there was a prolonged summer surge in California that lasted from June through the end of September. After that ...
New York Magazine on MSN3h
What’s Going on With Trump’s New COVID Vaccine Policies?On May 29, the Centers for Disease Control updated its childhood immunization schedule to say that healthy kids between the ...
Health Secretary Robert F. Kennedy Jr. recently announced more key changes to the CDC recommendations for COVID-19 ...
The Centers for Disease Control and Prevention now says that kids with no underlying health conditions "may receive" COVID-19 ...
Health Secretary Robert F. Kennedy Jr. said on Tuesday that the vaccine would no longer appear on the childhood immunization ...
Dr. Marty Makary, the Johns Hopkins surgeon and professor who Trump tapped to lead the FDA, clarified the recently changed ...
As influenza cases continue to rise in the lead up to winter, a new study has found that getting a COVID-19 booster at the ...
First identified in January, NB. 1.8.1 is spreading quickly across multiple countries, leading to an increase in cases and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback